BeiGene Highlights Waldenström's Macroglobulinemia Innovation at IWWM 2024

SAN MATEO, Calif.–(BUSINESS WIRE)–BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global oncology company, today announced it will …

Do you trust this headline?

Based on recent headline ratings, 82% of this readership currently trusts the local media, which has an average score of 82% regionally and is currently trending positiveneutrally.

82%

Media Trust Score82%

In